Gynecological Cancer Clinical Trial
Official title:
Evaluating Process and Effectiveness of Low-intensity Group Cognitive Behavioural Therapy for Women With Gynaecological Cancer: The EPELIT Study
There are 21,500 gynaecological cancers diagnosed in the UK each year. These are often
diagnosed later than common cancers, which is predictive of low survival and high
psychological distress. There are few studies published which accurately map the profile of
distress and supportive care needs in gynaecological cancer patients, nor which test
psychological interventions to support this group.
This study will use a non-randomised controlled trial design to explore the potential
benefits of taking part in a psychological intervention designed in this group of women. The
intervention is group-delivered and runs for eight weeks. It is delivered by psychologists,
psychological wellbeing practitioners, and cancer nurse specialists. The investigators will
use validated self-report questionnaires to assess how helpful this intervention is at
reducing distress and improving quality of life in the participants. This will be done in
comparison with a treatment-as-usual control group recruited from a second clinical site.
This second group of participants will not receive the psychological intervention, but they
will complete the same assessments, at the same time points. To ensure participants are well
supported, data collection in control control group participants will be done by telephone
interview rather than self-report questionnaires. Both groups of participants will undertake
a three-month follow-up assessment to check the longer-term effectiveness of the
psychological intervention.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03935698 -
Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study
|
N/A | |
Completed |
NCT01831089 -
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01703585 -
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
|
||
Completed |
NCT04694508 -
Intraoperative Music Therapy in Gynecological Oncology
|
N/A | |
Recruiting |
NCT03714581 -
Laser Therapy Following Radiotherapy for Gynecological Cancer
|
N/A | |
Recruiting |
NCT03740503 -
Genomic Investigation of Unusual Responders
|
||
Completed |
NCT02169908 -
Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin
|
N/A | |
Recruiting |
NCT05028504 -
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
|
Phase 2 | |
Completed |
NCT02026687 -
Recovery and Analgesia After Surgery for Gynecological Cancer
|
Phase 4 | |
Not yet recruiting |
NCT06039306 -
Perioperative Immunonutrition Under Enhanced Recovery After Surgery
|
N/A | |
Active, not recruiting |
NCT04341480 -
The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19
|
||
Recruiting |
NCT04236362 -
A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT02906943 -
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
|
||
Not yet recruiting |
NCT05003973 -
The Effectiveness of Anti-resistance Exercise on Lower Limb Lymphoedema Among Gynecological Cancer
|
N/A |